As we stand on the precipice of a scientific revolution, researchers are pushing the boundaries of biology by developing ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular innovation, today announced the official launch of ...

Metabolism plays a central role in maintaining physiological balance and overall health, influencing virtually every biological process. Coherently, ...

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...

NLS Pharmaceutics Ltd. ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system and neurodegenerative disorders, and Aexon Labs, a biotechnology company advancing ...

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under two years, despite ...

Glial cells have emerged as central regulators of neural homeostasis, immune surveillance, and disease propagation throughout ...

Winston Timp, the principal investigator of the Timp Lab and associate professor of Biomedical Engineering (BME) at the ...

Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps ...

Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It's the ...